Kodiak Sciences Announces Recent Business Highlights and Second Quarter 2024 Financial Results
Kodiak Sciences Inc (KOD)
Last kodiak sciences inc earnings: 11/12 05:30 am
Check Earnings Report
Company Research
Source: PR Newswire
PALO ALTO, Calif., Aug. 14, 2024 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), today reported business highlights and financial results for the quarter ended June 30, 2024."Our three clinical programs of tarcocimab, KSI-501 and KSI-101 are making strong operational progress," said Victor Perlroth, M.D., Chief Executive Officer of Kodiak Sciences. "The Phase 3 GLOW2 study of tarcocimab in diabetic retinopathy continues to enroll. The Phase 3 DAYBREAK study of tarcocimab and KSI-501 is now actively enrolling patients. DAYBREAK features an innovative study design that includes parallel investigational arms of tarcocimab and KSI-501 against aflibercept in wet AMD, and if successful, could support the marketing authorization applications for both investigational medicines. We have also activated the Phase 1b APEX study of KSI-101 in patients with macular edema secondary to inflammation, and the APEX study is now enrolling patients.""This past quarter we also strengthened our executiv
Show less
Read more
Impact Snapshot
Event Time:
KOD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
KOD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
KOD alerts
High impacting Kodiak Sciences Inc news events
Weekly update
A roundup of the hottest topics
KOD
News
- We Think Kodiak Sciences (NASDAQ:KOD) Needs To Drive Business Growth Carefully [Yahoo! Finance]Yahoo! Finance
- Kodiak Sciences to Host Investor R&D Day on September 23, 2024 in New York CityPR Newswire
- Kodiak Sciences Inc. (NASDAQ: KOD) is now covered by analysts at HC Wainwright. They set a "neutral" rating and a $3.00 price target on the stock.MarketBeat
- Kodiak (KOD) Q2 Loss Narrower Than Expected, Pipeline in Focus [Yahoo! Finance]Yahoo! Finance
- Kodiak Sciences Inc. (NASDAQ:KOD) is definitely on the radar of institutional investors who own 50% of the company [Yahoo! Finance]Yahoo! Finance
KOD
Earnings
- 8/14/24 - Beat
KOD
Analyst Actions
- 9/5/24 - HC Wainwright
KOD
Sec Filings
- 8/14/24 - Form 10-Q
- 8/14/24 - Form 8-K
- 8/7/24 - Form 4
- KOD's page on the SEC website